237 related articles for article (PubMed ID: 11669178)
1. Antibodies to beta 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection.
Kalt M; Gertner E
J Rheumatol; 2001 Oct; 28(10):2335-6. PubMed ID: 11669178
[TBL] [Abstract][Full Text] [Related]
2. Lupus-like presentation of parvovirus B19 infection.
Sève P; Ferry T; Koenig M; Cathebras P; Rousset H; Broussolle C
Semin Arthritis Rheum; 2005 Feb; 34(4):642-8. PubMed ID: 15692957
[TBL] [Abstract][Full Text] [Related]
3. Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?
Aslanidis S; Pyrpasopoulou A; Kontotasios K; Doumas S; Zamboulis C
Eur J Intern Med; 2008 Jul; 19(5):314-8. PubMed ID: 18549931
[TBL] [Abstract][Full Text] [Related]
4. [Human parvovirus B19 infection mimicking systemic lupus erythematosus: case report].
Banno S; Matsumoto Y; Sugiura Y; Ueda R
Ryumachi; 1997 Aug; 37(4):581-6. PubMed ID: 9311285
[TBL] [Abstract][Full Text] [Related]
5. Postpartum lupus erythematosus associated with parvovirus B19 infection.
Nigro G; Piazze J; Taliani G; Mazzocco M; Cassinotti P; Cosmi EV
J Rheumatol; 1997 May; 24(5):968-70. PubMed ID: 9150091
[TBL] [Abstract][Full Text] [Related]
6. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus.
Loizou S; Cazabon JK; Walport MJ; Tait D; So AK
Arthritis Rheum; 1997 Jan; 40(1):103-8. PubMed ID: 9008606
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
8. [Imitation of an acute exacerbation of established systemic lupus erythematosus caused by parvovirus B19 infection].
Langgartner J; Andus T; Hemauer A; Schölmerich J; Lang B
Dtsch Med Wochenschr; 1999 Jul; 124(28-29):859-62. PubMed ID: 10432949
[TBL] [Abstract][Full Text] [Related]
9. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
10. Human parvovirus B19 infection mimicking systemic lupus erythematosus in an adult patient.
Negro A; Regolisti G; Perazzoli F; Coghi P; Tumiati B; Rossi E
Ann Ital Med Int; 2001; 16(2):125-7. PubMed ID: 11688361
[TBL] [Abstract][Full Text] [Related]
11. [Systemic manifestations of Parvovirus B19 infections].
Sève P; Ferry T; Charhon A; Calvet A; Broussolle C
Rev Med Interne; 2004 Oct; 25(10):740-51. PubMed ID: 15471600
[TBL] [Abstract][Full Text] [Related]
12. Parvovirus B19-associated systemic lupus erythematosus: clinical mimicry or autoimmune induction?
Hession MT; Au SC; Gottlieb AB
J Rheumatol; 2010 Nov; 37(11):2430-2. PubMed ID: 21041264
[No Abstract] [Full Text] [Related]
13. Systemic lupus erythematosus associated with acute parvovirus B19 infection.
Díaz F; Collazos J; Mendoza F; De La Viuda JM; Cazallas J; Urkijo JC; Flores M
Clin Microbiol Infect; 2002 Feb; 8(2):115-7. PubMed ID: 11952726
[TBL] [Abstract][Full Text] [Related]
14. Lupus syndrome after parvovirus B19 infection.
Roblot P; Roblot F; Ramassamy A; Becq-Giraudon B
Rev Rhum Engl Ed; 1997 Dec; 64(12):849-51. PubMed ID: 9476277
[TBL] [Abstract][Full Text] [Related]
15. [Antibodies to beta2-glycoprotein-1 in patients with systemic lupus erythematosus].
Borodin AG; Baranov NG; Nasonov EL
Klin Med (Mosk); 2001; 79(2):49-51. PubMed ID: 11419087
[TBL] [Abstract][Full Text] [Related]
16. Significant association of past parvovirus B19 infection with cytopenia in both adult-onset Still's disease and systemic lupus erythematosus patients.
Chen DY; Chen YM; Lan JL; Tzang BS; Lin CC; Hsu TC
Clin Chim Acta; 2012 May; 413(9-10):855-60. PubMed ID: 22309679
[TBL] [Abstract][Full Text] [Related]
17. Chronic modulation of the autoimmune response following parvovirus B19 infection.
Vigeant P; Ménard HA; Boire G
J Rheumatol; 1994 Jun; 21(6):1165-7. PubMed ID: 7932438
[TBL] [Abstract][Full Text] [Related]
18. Human parvovirus B19 infection in children: uncommon clinical presentations.
Barash J; Dushnitzky D; Sthoeger D; Bardenstein R; Barak Y
Isr Med Assoc J; 2002 Oct; 4(10):763-5. PubMed ID: 12389336
[TBL] [Abstract][Full Text] [Related]
19. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
Ohtsuka T; Yamazaki S
Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
[TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular evidence for association of SLE with parvovirus B19.
Pavlovic M; Kats A; Cavallo M; Shoenfeld Y
Lupus; 2010 Jun; 19(7):783-92. PubMed ID: 20511275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
